These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 2574732
1. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma. Becker AB, Simons FE. J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732 [Abstract] [Full Text] [Related]
5. Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists. van Schayck CP, Cloosterman SG, Bijl-Hofland ID, van den Hoogen H, Folgering HT, van Weel C. Respir Med; 2002 Mar; 96(3):155-62. PubMed ID: 11908511 [Abstract] [Full Text] [Related]
6. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. Aalbers R, Boorsma M, van der Woude HJ, Jonkers RE. Respir Res; 2010 May 28; 11(1):66. PubMed ID: 20509942 [Abstract] [Full Text] [Related]
8. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours. Maesen FP, Smeets JJ, Gubbelmans HL, Zweers PG. Chest; 1990 Mar 28; 97(3):590-4. PubMed ID: 1968371 [Abstract] [Full Text] [Related]
9. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration. Löfdahl CG, Svedmyr N. Allergy; 1989 May 28; 44(4):264-71. PubMed ID: 2544117 [Abstract] [Full Text] [Related]
12. Twelve hours' bronchodilating effect of inhaled formoterol in children with asthma: a double-blind cross-over study versus salbutamol. Graff-Lonnevig V, Browaldh L. Clin Exp Allergy; 1990 Jul 28; 20(4):429-32. PubMed ID: 1973907 [Abstract] [Full Text] [Related]
13. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators. van der Molen T, Postma DS, Turner MO, Jong BM, Malo JL, Chapman K, Grossman R, de Graaff CS, Riemersma RA, Sears MR. Thorax; 1997 Jun 28; 52(6):535-9. PubMed ID: 9227720 [Abstract] [Full Text] [Related]
14. Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic. Derom EY, Pauwels RA. Thorax; 1992 Jan 28; 47(1):30-3. PubMed ID: 1539141 [Abstract] [Full Text] [Related]
16. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma. Wallin A, Sandström T, Rosenhall L, Melander B. Thorax; 1993 Jun 28; 48(6):611-4. PubMed ID: 8346490 [Abstract] [Full Text] [Related]
17. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Aziz I, Hall IP, McFarlane LC, Lipworth BJ. J Allergy Clin Immunol; 1998 Mar 28; 101(3):337-41. PubMed ID: 9525449 [Abstract] [Full Text] [Related]
19. Effects of treatment with formoterol on bronchoprotection against methacholine. Lipworth B, Tan S, Devlin M, Aiken T, Baker R, Hendrick D. Am J Med; 1998 May 28; 104(5):431-8. PubMed ID: 9626025 [Abstract] [Full Text] [Related]
20. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study. Sovijärvi AR, Reinikainen K, Freudenthal Y, Andersson P, Riska H. Respiration; 1992 May 28; 59(5):279-82. PubMed ID: 1488561 [Abstract] [Full Text] [Related] Page: [Next] [New Search]